Edwards Lifesciences Corporation (EW)
Makes artificial heart valves to replace or repair damaged ones without open-chest surgery.
$83.04+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+4.7%
The outlook
Edwards Lifesciences trades at $83.04, sitting below both its 50- and 200-day moving averages after a neutral day. Analysts broadly favor the stock with a "Buy" consensus, and the average price target sits about 21% above the current level. The stock sits roughly midway in its 52-week range, with a high trailing P/E of 49.4 reflecting investor expectations.
What’s behind the score
Analyst consensusBuy — 1.7 avg of 25 analysts
Price trendBelow its 50- & 200-day averages
52-week range45% of the way from its 52-week low to high
Price targetAvg target +21% vs current price
Analyst price target
~12-month · 25 analysts$100.48average target+21.0% vs now
Now $83.04
Low $84.00High $110.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$47.81B
52-wk high
$96.29
52-wk low
$72.30
50-day avg
$87.29
200-day avg
$83.46
Trailing P/E
49.4